Browse the corpus

REFERENCES American Academy of Pediatrics Committee on Drugs, "'Inactive' Ingredients in Pharmaceutical Products: Update (Subject Review)," Pediatr , 1997, 99(2):268-78. [PubMed 9024461 ] Aoki FY and Sitar DS, “Clinical Pharmacokinetics of Amantadine Hydrochloride,” Clin Pharmacokinet , 1988, 14(1):35-51. [PubMed 3280212 ] Beers SR, Skold A, Dixon CE, et al, "Neurobehavioral Effects of Amantadine After Pediatric Traumatic Brain Injury: A Preliminary Report," J Head Trauma Rehabil , 2005, 20(5):450-63. [PubMed 16170253 ] Bradley JS, Byington CL, Shah SS, et al, “The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America”, Clin Infect Dis , 2011, 53(7):e25-76. [PubMed 21880587 ] Centers for Disease Control and Prevention (CDC), "Influenza Division, National Center for Immunization and Respiratory Diseases. Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza --- Recommendations of the Advisory Committee on Immunization Practices (ACIP)," MMWR Surveill Summ , 2011, 60(1):1-28. [PubMed 21248682 ] Centers for Disease Control and Prevention (CDC), "Interim Guidance: Considerations Regarding 2009 Novel H1N1 Flu Virus in Intrapartum and Postpartum Hospital Settings," Available at file://www.cdc.gov/h1n1flu/guidance/obstetric.htm [PubMed 12755288 ] Centers for Disease Control and Prevention (CDC), "Prevention and Control of Influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP)," MMWR Recomm Rep, 2008, 56 (early release):1-60. Available at file://www.cdc.gov/mmwr/preview/mmwrhtml/rr57e717a1.htm Chitnis T, Krupp L, Yeh A, et al, "Pediatric Multiple Sclerosis," Neurol Clin , 2011, 29(2):481-505. [PubMed 21439455 ] Donfrancesco R, Calderoni D, and Vitiello B, "Open-Label Amantadine in Children With Attention-Deficit/Hyperactivity Disorder," J Child Adolesc Psychopharmacol , 2007, 17(5):657-64. [PubMed 17979585 ] Giacino JT, Whyte J, Bagiella E, et al, "Placebo-Controlled Trial of Amantadine for Severe Traumatic Brain Injury," N Engl J Med , 2012, 366(9):819-26. [PubMed 22375973 ] Green LB, Hornyak JE, and Hurvitz EA, "Amantadine in Pediatric Patients With Traumatic Brain Injury: A Retrospective, Case-Controlled Study," Am J Phys Med Rehabil , 2004, 83(12):893-7. [PubMed 15624567 ]

Giacino JT, Whyte J, Bagiella E, et al, "Placebo-Controlled Trial of Amantadine for Severe Traumatic Brain Injury," N Engl J Med , 2012, 366(9):819-26. [PubMed 22375973 ] Green LB, Hornyak JE, and Hurvitz EA, "Amantadine in Pediatric Patients With Traumatic Brain Injury: A Retrospective, Case-Controlled Study," Am J Phys Med Rehabil , 2004, 83(12):893-7. [PubMed 15624567 ] King BH, Wright DM, Handen BL, et al, "Double-Blind, Placebo-Controlled Study of Amantadine Hydrochloride in the Treatment of Children With Autistic Disorder," J Am Acad Child Adolesc Psychiatry , 2001a, 40(6):658-65. [PubMed 11392343 ] King BH, Wright DM, Snape M, et al, "Case Series: Amantadine Open-Label Treatment of Impulsive and Aggressive Behavior in Hospitalized Children With Developmental Disabilities," J Am Acad Child Adolesc Psychiatry , 2001, 40(6):654-7. [PubMed 11392342 ] McMahon MA, Vargus-Adams JN, Michaud LJ, et al, "Effects of Amantadine in Children With Impaired Consciousness Caused by Acquired Brain Injury: A Pilot Study," Am J Phys Med Rehabil , 2009, 88(7):525-32. [PubMed 19404190 ] Mohammadi MR, Kazemi MR, Zia E, et al, "Amantadine Versus Methylphenidate in Children and Adolescents With Attention Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Trial," Hum Psychopharmacol , 2010, 25(7-8):560-5. [PubMed 21312290 ] Patrick PD, Blackman JA, Mabry JL, et al, "Dopamine Agonist Therapy in Low-Response Children Following Traumatic Brain Injury," J Child Neurol , 2006, 21(10):879-85. [PubMed 17005105 ] Pohl D, Waubant E, Banwell B, et al, "Treatment of Pediatric Multiple Sclerosis and Variants," Neurology , 2007, 68(16 Suppl 2):54-65. [PubMed 17438239 ] Strong DK, Eisenstat DD, Bryson SM, et al, “Amantadine Neurotoxicity in a Pediatric Patient With Renal Insufficiency,” DICP , 1991, 25(11):1175-7. [PubMed 1763530 ] Thompson AJ, Toosy AT, and Ciccarelli O, "Pharmacological Management of Symptoms in Multiple Sclerosis: Current Approaches and Future Directions," Lancet Neurol , 2010, 9(12):1182-99. [PubMed 21087742 ] Vargus-Adams JN, McMahon MA, Michaud LJ, et al, "Pharmacokinetics of Amantadine in Children With Impaired Consciousness Due to Acquired Brain Injury: Preliminary Findings Using a Sparse-Sampling Technique," PMR , 2010, 2(1):37-42. [PubMed 20129511 ] Williams SE, "Amantadine Treatment Following Traumatic Brain Injury in Children," Brain Inj , 2007, 21(9):885-9. [PubMed 17729042 ]

Vargus-Adams JN, McMahon MA, Michaud LJ, et al, "Pharmacokinetics of Amantadine in Children With Impaired Consciousness Due to Acquired Brain Injury: Preliminary Findings Using a Sparse-Sampling Technique," PMR , 2010, 2(1):37-42. [PubMed 20129511 ] Williams SE, "Amantadine Treatment Following Traumatic Brain Injury in Children," Brain Inj , 2007, 21(9):885-9. [PubMed 17729042 ] Topic 13387 Version 39.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0605-61.234.146.186-869C284B9E-S244013.14]